rs202146491

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_015235.3(CSTF2T):​c.1624G>A​(p.Gly542Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000482 in 1,599,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

CSTF2T
NM_015235.3 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.731

Publications

1 publications found
Variant links:
Genes affected
CSTF2T (HGNC:17086): (cleavage stimulation factor subunit 2 tau variant) Enables RNA binding activity. Predicted to be involved in pre-mRNA cleavage required for polyadenylation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
PRKG1 (HGNC:9414): (protein kinase cGMP-dependent 1) Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]
PRKG1 Gene-Disease associations (from GenCC):
  • aortic aneurysm, familial thoracic 8
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD, Unknown Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018237919).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015235.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSTF2T
NM_015235.3
MANE Select
c.1624G>Ap.Gly542Ser
missense
Exon 1 of 1NP_056050.1Q9H0L4
PRKG1
NM_006258.4
MANE Select
c.593-106659C>T
intron
N/ANP_006249.1Q13976-2
PRKG1
NM_001098512.3
c.548-106659C>T
intron
N/ANP_001091982.1Q13976-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSTF2T
ENST00000331173.6
TSL:6 MANE Select
c.1624G>Ap.Gly542Ser
missense
Exon 1 of 1ENSP00000332444.4Q9H0L4
PRKG1
ENST00000373980.11
TSL:1 MANE Select
c.593-106659C>T
intron
N/AENSP00000363092.5Q13976-2
PRKG1
ENST00000401604.8
TSL:5
c.548-106659C>T
intron
N/AENSP00000384200.4Q13976-1

Frequencies

GnomAD3 genomes
AF:
0.0000660
AC:
10
AN:
151496
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000975
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000537
AC:
12
AN:
223544
AF XY:
0.0000498
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000196
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000628
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000404
Gnomad OTH exome
AF:
0.000178
GnomAD4 exome
AF:
0.0000463
AC:
67
AN:
1447538
Hom.:
0
Cov.:
31
AF XY:
0.0000403
AC XY:
29
AN XY:
719018
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000609
AC:
2
AN:
32842
American (AMR)
AF:
0.000216
AC:
9
AN:
41736
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25906
East Asian (EAS)
AF:
0.0000517
AC:
2
AN:
38686
South Asian (SAS)
AF:
0.0000235
AC:
2
AN:
84948
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52762
Middle Eastern (MID)
AF:
0.000869
AC:
5
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000371
AC:
41
AN:
1104966
Other (OTH)
AF:
0.000100
AC:
6
AN:
59936
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.349
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000660
AC:
10
AN:
151614
Hom.:
0
Cov.:
32
AF XY:
0.0000540
AC XY:
4
AN XY:
74102
show subpopulations
African (AFR)
AF:
0.0000972
AC:
4
AN:
41158
American (AMR)
AF:
0.000131
AC:
2
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5072
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67932
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
ExAC
AF:
0.0000495
AC:
6

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
5.6
DANN
Benign
0.31
DEOGEN2
Benign
0.062
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.046
N
LIST_S2
Benign
0.51
T
M_CAP
Benign
0.0070
T
MetaRNN
Benign
0.018
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.73
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.15
N
REVEL
Benign
0.024
Sift
Benign
0.066
T
Sift4G
Benign
0.24
T
Polyphen
0.0010
B
Vest4
0.28
MVP
0.18
MPC
0.23
ClinPred
0.024
T
GERP RS
1.4
Varity_R
0.11
gMVP
0.67
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202146491; hg19: chr10-53457686; API